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Figure 2. Patella.
Figure 3. Trochlea.
increased, but its volume was reduced after three weeks of running,
becoming signiﬁcant after 12 weeks (p=0.0007) (Figure 2). Attenuation
was signiﬁcantly increased in trochlear cartilage at 12 weeks (p=0.009),
although not signiﬁcant, trochlear cartilage volume showed a clear trend of
reduction from one to 12 weeks (Figure 3).
Conclusions: With CECT we successfully analyzed OA progression in knee
joints of strenuous running Wistar rats. Our data suggests that 6 weeks of
running damages cartilage beyond the ability for repair, which results in
OA progression even when rats are not forced to run anymore. In addition,
we demonstrate that besides disease progression at the weight-bearing
condyles, the articular cartilage of the femoral bone and the patella is also
affected. Our ﬁndings demonstrate that this model could very well be used
for testing DMOADs, also after the OA inducing running stimulus has been
stopped. In such a study, (regenerative) compounds can be tested without
the stimulus inducing OA and counteracting a possible positive effect of the
studied drug.
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TREATMENT WITH AN AGGRECANASE SPECIFIC INHIBITOR AND LUBRICIN
SIGNIFICANTLY REDUCES JOINT PAIN IN A RAT MODEL OF
POST-TRAUMATIC ARTHRITIS
M.A. Rivera-Bermudez, J. Tejada, T.J. Blanchet, S. Soucy, L. Savary,
K. Georgiadis, C.R. Flannery, S.S. Glasson
Pﬁzer, Cambridge, MA
Purpose: Traumatic joint injuries lead to an increased incidence of acceler-
ated and progressive loss of the normal structure and function of articular
cartilage, resulting in pain and signiﬁcant disability. The rat meniscal tear
(MT) model of post-traumatic arthritis (PTA) is a primary in vivo system for
testing the ability of potential therapeutics to slow cartilage degradation
and pain following acute injury. It has previously been demonstrated that
treatment with either an aggrecanase speciﬁc inhibitor (ASI) or recom-
binant lubricin is chondroprotective in the rat MT model. In the current
study, we evaluated the effect of treatment with ASI and Lubricin, either
dosed separately or in combination, on pain in this model.
Methods: All in vivo experimental procedures were IACUC reviewed and
approved. Male Lewis rats underwent medial MT surgery on the right knee
to induce joint instability. Study #1: rats were dosed with vehicle, 60
mg/kg/day ASI (PO, starting on the day of surgery), 20 μg of intra-articular
(IA) recombinant lubricin (LUB1; 3X/week, starting one week post-surgery)
or combined dosing with both ASI and LUB1. Dosing was terminated
5 weeks post-surgery. Study #2 replicate the dosing paradigm in study
1, but at 5 weeks post-surgery, dosing ceased and the study continued
for an additional 5 weeks. The change in hind paw weight distribution
between the ipsilateral knee and contra-lateral knee was measured with
an incapacitance meter (Linton, CO) at various time points.
Results: Treatment with ASI and LUB1 signiﬁcantly reduced pain 4 weeks
after surgery. Moreover, combination therapy of ASI and LUB1 proved more
eﬃcacious than either therapy alone. Both ASI and LUB1 continued to
ameliorate pain at 2 and 3 weeks after dose cessation.
Conclusions: The present study demonstrates that ASI and LUB1, both
separately, and to a greater extent in combination, have the potential to
signiﬁcantly reduce joint injury-associated pain during the progression of
PTA. Treatment with ASI and LUB1 alone also proved eﬃcacious in reducing
pain 3 weeks after dose termination, suggesting that the effect on pain
can be prolonged for a substantial period after ASI and LUB1 treatment
cessation. These results support the development of ASI and LUB1 as
potential therapies following joint injuries in humans, to provide both pain
relief as well as chondroprotection.
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USE OF GAIT ANALYSIS AS AMEASURE OF SPONTANEOUS PAIN BEHAVIOR
IN MURINEMODELS OF ARTHRITIS
C. Dorman1, H.E. Krug2,1, S.R. Anderson2, S.V. Frizelle1, M.L. Mahowald2,1
1VA Med. Ctr., Minneapolis, MN; 2Univ. of Minnesota, Minneapolis, MN
Purpose: Murine models of arthritis are important tools for the study of
arthritis pain and discovery of new analgesic therapies, however measuring
pain in mice can be challenging. We have previously described sensitive
and speciﬁc methods for measuring evoked pain behaviors in mice with
acute and chronic arthritis pain. But it is also desirable to incorporate the
measurement of spontaneous behaviors that are sensitive to change with
pain and analgesia. We have used two methods of digitized gait analysis to
detect changes in spontaneous gait behavior in order to quantify pain in
murine models of arthritis and to detect analgesic responses.
Methods: C57Bl6 mice were used for all experiments. In all cases arthritis
was produced only in the left knee. Chronic arthritis was produced by IA
injection of 10 IU Collagenase. Acute inﬂammatory arthritis was produced
by IA injection of 10 μl 3% carrageenan. Analgesia was provided by
Botulinum toxin type A (BoNT/A) (0.02 IU) which was given IA into the
left knee 3 days before testing. The normal right knee served as internal
nonpainful control. Mice were studied in the naïve pre-arthritic state, after
induction of arthritis and after IA BoNT/A or saline control treatment.
Video gait analysis was performed using DigiGait™ (Mouse Speciﬁcs, Inc,
Quincy, MA) hardware and software and TreadScan digitized gait analysis
system (Clever Sys, Inc. Reston, VA) Evoked pain behavior was measured by
tallying ﬁghts + vocalizations/1 min in response to repeated ﬁrm palpation
of the knee preformed by a single, trained examiner. Strength was observed
visually and graded semiquantitatively as ability to grasp and cling to
a wire grid. Visual assessment of gait was also performed and similarly
graded. Student’s t-test was used for statistical comparisons.
Results: No mouse appeared weak as a result of BoNT/A injection. Arthritis
pain was clearly and reproducibly indicated by increased Evoked pain
scores in both acute inﬂammatory and chronic noninﬂammatory arthritic
mice. Analgesia after BoNT/A injection was modest in acute inﬂammatory
arthritis and did not reach statistical signiﬁcance. Anagesia after BoNT/A
was statistically signiﬁcant in mice with chronic arthritis as measured by
Evoked pain scores. Although gross abnormalities of gait could be seen by
visual observation in arthritic mice, speciﬁc alterations in gait parameters
were less common, of small magnitude, and somewhat inconsistent. Similar
results were obtained using two different gait analysis systems. As might
be expected in a quadruped, alterations in gait due to pain did not appear
to be conﬁned to the arthritic limb, but these results were not consistent.
Evoked Pain Response - Left Knee
Mean (SEM) Non-Arthritic Arthritic BoNT/A Rx Saline Rx
Chronic Non-Inﬂammatory Arthritis 2.0 (0.76) 8.2 (1.22) 4.5 (1.04) 8.2 (2.39)
Acute Inﬂammatory Arthritis 1.3 (0.49) 12.8 (3.41) 6.1 (1.21) 10.0 (2.69)
Conclusions: Pain can be quantitated in murine models of arthritis using
visual and computerized gait analysis, and evoked pain scores. Evoked
pain responses increased signiﬁcantly with arthritis and decreased with IA
BoNT/A and appear to be reliable and reproducible. No limb weakness was
noted. Although gross changes in gait can be seen in animals with arthritis,
detection by digitized gait analysis is subject to individual variation, and
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caution must be used in interpreting results. Great care must be taken
to normalize background characteristics, standardize measurements and
interpret results in the context of various gaits utilized by quadrupeds.
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TIME-COURSE MICRO-CT IMAGING OF BONE CHANGES IN THE RAT
ACLTpMx AND MIA MODEL
E. Bartnik1, X. Ying2, J. Ji2, K. Rudolphi1, N. Barlow2, M.A. Zulliger3,
K. Arndt1
1Sanoﬁ-Aventis, Frankfurt, Germany; 2Sanoﬁ-Aventis, Bridgewater, NJ; 3Scanco
Med., Bruettisellen, Switzerland
Purpose: Osteoarthritis (OA) is a disease of the whole joint, including
cartilage, synovium, ligaments and bone. The contribution of bone changes
to the disease is not well understood. We used μCT imaging to determine
the time course of bone parameter changes in the rat Anterior Cruciate
Ligament Transection plus Partial Medial Meniscectomy (ACLTpMx) model
and the rat Monoiodoacetate (MIA) model.
Methods: The ACLTpMx operation was used to induce OA-like changes. 70
male Lewis rats were assigned to the following groups: 3, 7, 14, 28, 42 days
post ACLTpMx surgery, no surgery and sham surgery. At 3, 7, 14, 28, 42
days post ACLTpMx animals were sacriﬁced.
In a second set of animals [n=3], 1 mg/joint of MIA was injected into the
knee to induce joint damage. 17 and 39 days after injection, NaCl-control
and MIA-injected animals were sacriﬁced. For the bone/cartilage μCT imag-
ing, each distal femur was immersed in an ionic CT contrast agent solution
(30% Hexabrix in phosphate buffered saline) for 25 min at ∼21°C, then
the surface liquid absorbed and the femur was immediately transferred
to the μCT system (SkyScan 1172, SkyScan, Belgium), with the setting of
50kVp/200μA, 0.5 mm aluminium ﬁlter and 20 μm3 imaging voxel size.
The images were imported and analyzed using SCANCO Medical Evaluation
Software (SCANCO Medical AG, Switzerland). Reference average epiphyses,
generated after registration and summation of all studied epiphyses, served
as guides to determine regions of interest (weight bearing, central areas
of the medial and lateral tibial plateau, Fig. 1) for the medial and lateral
tibial plateaus, which were overlaid onto each individual epiphysis. Using
the deﬁned ROIs, the analyzed structures were cut cookie-cutter-style and
further analyzed to provide standard morphometric bone parameters.
Figure 1. Regions of interest overlaid on the medial (M) and lateral (L) tibial plateau.
Results: Bone volume, BV/TV, structural model index (SMI) and marrow
thickness (trabecular separation Tb.Sp) tend to increase with the age of the
animals. ACLTpMx induced changes within the epiphysis were recognizable
7 days after the ACLTpMx procedure, reaching a maximum around 14 days
and subsequently subsiding. By 42 days after the operation, the ACLTpMx
induced changes had returned to normal. Tb:Sp reﬂected the most promi-
nent ACLTpMx induced effect, but did not reach statistical signiﬁcance
comparing values at Day 3 with values at Day 14.
Figure 2. Time course of bone marrow thickness within the ROI in the medial and lateral
epiphyses at different times after ACLTpMx.
MIA induced far greater effects on bone parameters compared to ACLTpMx.
17 days after MIA injection, bone volume and mean thickness of bone struc-
tures had increased (comparing NaCl and MIA injected groups), whereas
trabecular connectivity had decreased. At 39 days the differences were
much less prominent.
Conclusions: μCT extends our ability to monitor changes in OA models
to bone parameters. Trends of bone parameter changes are evident for
both the ACLTpMx as well as for the MIA model. The most obvious
changes correlate with the age of the animals and thus should reﬂect
growth-related changes. These were seen in both the medial and the lateral
tibial compartment. The changes seen as a result of the ACLTpMx occurred
only in the medial compartment, where most of the cartilage damages
occur in this model. These changes appear 7 days after surgery hinting
at the adaptability of bone structures. Although the changes were quite
evident, their range of fold-change is rather small not reaching statistical
signiﬁcance. Therefore one needs to reﬁne those measurements, i.e. by
further deﬁning the ROIs to use those parameters to describe the effect of
structure modifying compounds.
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CAN ANIMAL MODELS APPROXIMATE THE CHARACTERISTICS OF HUMAN
SUBCHONDRAL BONE?
M. Hurtig, M. Lowerison, S. Allendorf, A. Bell
Univ. of Guelph, Guelph, ON, Canada
Purpose: To characterize the subchondral bone plate (SBPlate) in normal
animals and humans. Our hypothesis was that the human subchondral
bone plate is unique and not comparable to quadruped animals. The
SBPlate is important in the understanding of osteoarthritis (OA) initiation
and progression as both sclerosis and porosity have been implicated as
contributing factors. The SBP is also important because it constitutes a
barrier to extrinsic cartilage repair. Animal models of cartilage repair
and regeneration are used to validate new cell- and biomaterial-based
interventions.
Methods: Normal medial femoral condyles from adult humans and animals
(n=4 each species) underwent microCT imaging at 45μ resolution (GE
Locus Explore). The resulting images were analyzed using 3×3×10 mm
regions of interest (ROIs) created starting at the tidemark and extending
through the SBPlate where bone mineral density (BMD), tissue mineral
density (TMD) and bone volume fraction (BVF) were determined using
Microview 2.2 (ABA). Additional depth-wise analyses of these regions were
done by expressing the mean voxel densities in each horizontal slice by
depth starting at the tidemark. Dicom images were converted to text
ﬁles and truncated to the POIs, then processed through custom scripts in
Python 3.1.1 and R (www.r-project.org). These scripts execute calibrations
to convert voxel HU to BMD in mg/cc or apply a user controlled threshold
to generate BVF (%).Data from depth-wise analyses was plotted by distance
from the articular surface. In addition, rate of change of BMD, TMD, and BVF
was investigated as a way of determining the subchondral plate thickness.
Results: Human SBP BMD and TMD in standard ROIs was signiﬁcantly
lower (p<0.05) than all animal species except the sheep and dog. Human
BVF was the lowest of all species (Figs. 1 and 2). Rate of change in BMD
Figure 1
